Hot Economic News Releases

Coface, which announced Monday a further improvement in results due to the recovery of its performance in the insurance authorized by a decrease in claims and believes that its results any credibility to public offerings.

The credit insurer, 100% subsidiary of Natixis, the subject of strategic thinking since last February in BPCE, parent company of Natixis on his future within the banking group.

Commenting on the results of Coface published on Monday its chief executive, Jerome Cazes, said at a press conference that discussions had not been completed and that there was "no urgency".

However, he said "feel that the scenario of a public offerings in 2011 is gaining credibility with the results" the first half.

The credit insurer is considered unlikely scenario of recurrent growth under the policy followed by recovery in the United States and China and the dynamism of world trade, and expects a further improvement in claims in the second half.

"This situation (macroeconomic) can anticipate the second half a further improvement in claims, continued cost control and growth turned positive in its turnover," notes Jerome Cazes.

The company saw its second quarter results continued the recovery started in the last quarter of 2009, with operating income of 31 million euros after a loss of 76 million a year earlier and a positive result of 24 million in the first quarter of year.

PERFORMANCE ASSURANCE

Driven mainly by the insurance, which rebounded thanks to a decline in claims, despite a turnover fell 2% at constant rates to 303 million euros while the ratio claims fell to 59% in the second quarter, against 63% in the first.

Coface's objective is a loss ratio between 45% and 50% in the next 18 months as well as productivity gains three points per year.

Operating income from insurance activities has reached 31 million euros, against a loss of 126 million a year earlier and a positive result of 24 million in the first quarter of 2010.

In services, where sales fell 8% to 65 million euros, operating profit was halved to six million euros while in factoring it increased to 10 million EUR cons has a two million earlier, on sales up sharply (+21% to 29 million euros)

Net profit stood at 20 million euros, against a loss of 37 million a year earlier and a profit of 15 million in the first quarter.

Shareholders' equity improved to 1.311 million euros, signing up 21% from the end of 2009 and 11% from the end of 2007, before the outbreak of the financial crisis, mainly driven by the capital increase occurred at Natixis first quarter.

As part of its strategic plan 2010-2012, after which Coface is a net profit of 250 million euros, the group also wants to become a rating agency that specializes in financial firms.

In response to criticisms of credit insurance during the crisis, the company has introduced a free access to its insured ratings to their clients.

Mizuho Financial Group, Sumitomo Mitsui Financial Group and Mitsubishi UFJ Financial Group can view each more than 100 billion yen (885 million) profit for April-June period, reports the Nikkei newspaper.

The newspaper claims that large Japanese banks have grown their results for their fiscal first quarter thanks to their trading operations, while recording lower losses on bad loans through a smaller number of large bankruptcies.

Mizuho, which posted a loss of 4.4 billion yen for the period April to June 2009 due to losses on the CDS (credit default swaps) should post a profit of around 150 billion yen for the same period this year with its trading, the Nikkei wrote.

Sumitomo Mitsui Financial Group should in turn generate between 150 and 200 billion yen profit, against a profit of 72.7 billion last year, the newspaper said without citing sources.

Mitsubishi UFJ Financial Group for its part should record a profit of more than 100 billion yen, against 75.9 billion a year earlier, writes the Nikkei.

Banks are under pressure to improve their credit operations, while long term rates are at their lowest level in five years, also highlighted the daily.

Johnson & Johnson Tuesday reported a quarterly revenue well below expectations and has revised downward its forecast of annual profit for the second time in a year due to repeated withdrawals from the market painkiller Tylenol and other group of drugs available without prescription.

By mid-session on Wall Street, the title of group care products and U.S. health yielded 2.59% to 58.02 dollars while the Dow Jones, including Johnson & Johnson is, retreated from 0 84%.

The company said in the wake of its results have received a subpoena from the attorney general's office in Philadelphia as part of its withdrawal, without saying more.

For their part, the federal prosecutor's office did not confirm or comment on this procedure.

Johnson & Johnson said that global sales of its consumer goods were down 5.4% over the second quarter to 3.6 billion dollars.

The sales performance was mainly affected by the withdrawal, on April 30 last, a forty drugs used in the treatment of benign childhood diseases.

This decision was taken following a report showing that U.S. health authorities these products had been contaminated by dust and dirt during their manufacture in the factory of J & J in Fort Washington (Pennsylvania), finally closed end April.

The withdrawal of the products involved have cut sales of approximately $ 200 million, said Chief Financial Officer Dominic Caruso during a conference call, adding that closing the plant in Fort Washington is likely to weigh up 600 million dollars in annual sales.

The total turnover of Johnson & Johnson has also been weighed down by a slowdown in sales growth of its medical tools and diagnostic instruments.

The turnover stood at 15.33 billion dollars (0.6%) while analysts on average expected 15.64 billion, according to Thomson Reuters I / B / E / S.

Net income rose to 3.45 billion dollars (2.68 billion euros), or $ 1.23 per share against 3.21 billion ($ 1.15 per share) a year ago.

Excluding items, J & J posted earnings per share of $ 1.21, a level consistent with the average forecast of analysts.

The group has now said it expects earnings per share of between 4.65 and $ 4.75 throughout the year against a previous estimate of 4.80 to 4.90 dollars.

To explain this further revision downward, Johnson & Johnson raised the closure of the plant, which is currently undergoing a costly up to standard, and the pressure existing in Europe on the prices of its prescription drugs .

National Australia Bank is expected to introduce in the space of one week a new proposal to the Australian competition authorities on its bid of 11.5 billion dollars (9.13 billion euros) over the asset manager AXA Asia Pacific , a subsidiary of AXA, say three sources familiar with the matter.

NAB, which attempts to revive the business after losing the first time in April by the Australian Competition Commission (ACCC) would seek a further extension of its exclusivity few weeks from Axa to finalize its offer, added the sources.

The exclusive agreement between NAB and Axa expires July 15 and, in the opinion of the sources, Axa will extend it to allow time for competition authorities to assess the new proposal.

NAB and AXA AP have declined comment.

The ACCC had estimated in April that a merger between NAB and AXA would significantly reduce competition in the market for retail investment platforms.

To satisfy the commission, NAB may sell retail platforms AXA AP, North, for example.According to sources, discussions are underway on this with the fund manager IOOF Australia.

The Director General NAB Cameron Clyne said Wednesday shareholders that "NAB continues to evaluate its options for the approval of the ACCC's proposed purchase of subsidiaries in Australia and New Zealand AXA Asia Pacific" .

The opportunities are scarce for AXA, to the extent that the manager Australian PMI is also in the running but a recent decline in its share has reduced his ability to effectively make a competing offer, which it has yet received approval from the ACCC .

The Belgian bank insurer KBC sold its derivatives in Asia for about $ one billion, as part of restructuring promised in exchange for public assistance received during the crisis.

The buyer of Global Convertible Bond and Asian Equity Derivatives is Daiwa Capital Markets, the investment banking arm of Daiwa Securities of Japan.

The transaction will result in a strengthening of the capital of KBC and an increase of ten basis points from its Tier One ratio of liabilities to equity reported "hard".

The group, which received seven billion euros in state aid during the crisis, has agreed, in agreement with the European Commission to reduce its risky assets of 39 billion euros between 2008 and 2013, mainly by reducing its activities on financial markets and corporate lending internationally.

For its part, Daiwa seeks to develop its activities in Asia to take advantage of growth in the region after reducing its alliance in investment banking business with the Japanese bank Sumitomo Mitsui Financial Group.

KBC also said Monday it had sold to the Australian insurer QBE Insurance Secura its reinsurance subsidiary based in Brussels for 267 million euros.

QBE has made over 75 acquisitions over the last ten years to be present in 47 countries.

In May, KBC has raised 1.35 billion euros by selling its private banking arm KBL European Private Bankers to the Indian company Hinduja Group.

KBC closed the business in Japan in March. Analysts, traders and sellers of office of KBC in Tokyo have been committed by BNP Paribas.

Talks planned on Monday evening of 7 June in Berlin between German Chancellor Angela Merkel and French President Nicolas Sarkozy have been canceled, officials said the embassy of France.

Mr Sarkozy and Ms Merkel had planned a working dinner prepared especially for the EU summit in Brussels June 17, to discuss European economic coordination, on which they disagree substantially.

Read our article on the subject: Why France and Germany do not understand

The German chancellor had earlier announced the cancellation of meetings with the press. No explanation was immediately available. According to diplomatic sources, the encounter between the two leaders was postponed to Monday, June 14